Clinical Trial Update: Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tolcapone for cognitive and behavioral dysfunction in patients with traumatic brain injury and neurocognitive disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Disorder
• Traumatic Brain Injury

Drugs mentioned

• Tasmar (tolcapone)

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: Brain Injuries, Traumatic, Neurocognitive Disorders | Phase 2 | Status: UNKNOWN